Atlas Trials

European Study Evaluating the EMBLOK Embolic Protection System During TAVR

Clinical trial NCT03130491 · COMPLETED

Trial details

NCT number
NCT03130491
Sponsor
Emblok, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Aortic Valve Disease
Start date
2017-03-08
Primary completion
2021-11-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.